Frontiers in Immunology (May 2024)

Extracellular vesicles in non-small cell lung cancer stemness and clinical applications

  • Prita Pandya,
  • Prita Pandya,
  • Dania S. Al-Qasrawi,
  • Skyeler Klinge,
  • Skyeler Klinge,
  • Verline Justilien,
  • Verline Justilien

DOI
https://doi.org/10.3389/fimmu.2024.1369356
Journal volume & issue
Vol. 15

Abstract

Read online

Non-small cell lung carcinoma (NSCLC) accounts for 85% of lung cancers, the leading cause of cancer associated deaths in the US and worldwide. Within NSCLC tumors, there is a subpopulation of cancer cells termed cancer stem cells (CSCs) which exhibit stem-like properties that drive NSCLC progression, metastasis, relapse, and therapeutic resistance. Extracellular vesicles (EVs) are membrane-bound nanoparticles secreted by cells that carry vital messages for short- and long-range intercellular communication. Numerous studies have implicated NSCLC CSC-derived EVs in the factors associated with NSCLC lethality. In this review, we have discussed mechanisms of EV-directed cross-talk between CSCs and cells of the tumor microenvironment that promote stemness, tumor progression and metastasis in NSCLC. The mechanistic studies discussed herein have provided insights for developing novel NSCLC diagnostic and prognostic biomarkers and strategies to therapeutically target the NSCLC CSC niche.

Keywords